Starsource Multitrade

Starsource Multitrade Equity Growth

The Year-over-Year Equity Growth of Starsource Multitrade (506365.BO) as of Oct 27, 2026 is -90.19 %. In the previous year, Year-over-Year Equity Growth was 2.67 % — a change of -3,474.34% (lower).

Equity Growth

-90.19 %

YoY

-3,474.34%

Last updated:

Year-over-Year Equity Growth of Starsource Multitrade is 2026 -90.19 % . Year-over-Year Equity Growth of Starsource Multitrade was 2025 2.67 % . It decreases by -3,474.34% lower compared to the previous year.

The Starsource Multitrade Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2019
2.04 INR
Jan 1, 2020
4.02 INR
Jan 1, 2021
2.33 INR
Jan 1, 2022
5.09 INR
Jan 1, 2023
0.41 INR
Jan 1, 2024
10.35 INR
Jan 1, 2025
2.67 INR
Jan 1, 2026
-90.19 INR
The Starsource Multitrade Equity Growth history
YEAREquity GrowthYoY
-90.19 %-3,474.34%
2.67 %-74.17%
10.35 %+2,427.28%
0.41 %-91.96%
5.09 %+118.82%
2.33 %-42.09%
4.02 %+97.23%
2.04 %+102.96%
1.00 %-99.42%
172.88 %-711.17%
-28.29 %-605.98%
5.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Year-over-Year Equity Growth of Starsource Multitrade is -90.19 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Starsource Multitrade historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Starsource Multitrade

All Key Metrics — Starsource Multitrade